Endocrinology and Metabolism10.3803/enm.2021.10462021365977-987The Effects of Glucose Lowering Agents on the Secondary Prevention of Coronary Artery Disease in Patients with Type 2 DiabetesInha Jung, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Eun-Jung Rhee, Won-Young Lee,,
Journal of Diabetes and its Complications10.1016/j.jdiacomp.2008.07.0032009236427-433Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agentsMatteo Anselmino,
Diabetes & Metabolism10.1016/j.diabet.2018.10.0032019452110-121Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetesA.J. Scheen,
Chronic Coronary Artery Disease10.1016/b978-0-323-42880-4.00030-32018479-487Secondary Prevention of Coronary Artery DiseaseKarol E. Watson, Yuanlin Guo, Sheila Sahni,
Diabetes & Metabolism10.1016/j.diabet.2014.03.0042014403176-185Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: A critical reappraisalA.J. Scheen, B. Charbonnel,
Yearbook of Cardiology10.1016/s0145-4145(09)79551-620092009312-313Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After coronary Artery Bypass SurgeryB.J. Gersh,
Atherosclerosis Supplements10.1016/s1567-5688(07)71456-3200781126-127PO16-446 SUSTAINED SUBOPTIMAL SECONDARY PREVENTION OF CORONARY ARTERY DISEASE IN TYPE 2 DIABETES: AN ANALYSIS OF 41300 PATIENTS OVER 3 YEARSH. Voller, K. Bestehorn, C. Jannowitz, R. Reibis, K. Wegscheider,
Yearbook of Medicine10.1016/s0084-3873(09)79450-720092009402-404Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass SurgeryB.J. Gersh,
Diabetes and Vascular Disease Research10.1177/14791641198456122019165399-414Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndromeAngelo Avogaro, Enzo Bonora, Agostino Consoli, Stefano Del Prato, Stefano Genovese, Francesco Giorgino,,
The American Journal of Cardiology10.1016/s0002-9149(98)90428-319988210S28-S30Primary and secondary prevention of coronary artery disease: Trials of lipid lowering with statinsThomas A. Pearson,